Related Experiment Video
Updated: Apr 17, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
Immunotargeting of cancer stem cells
Eliza P Kwiatkowska-Borowczyk1, Agnieszka Gąbka-Buszek2, Jakub Jankowski2
1Department of Cancer Immunology, University of Medical Sciences, Poznan, Poland ; Diagnostic and Immunology Department, Greater Poland Cancer Centre, Poznan, Poland.
Abstract:
Cancer stem cells (CSCs) represent a distinctive population of tumour cells that control tumour initiation, progression, and maintenance. Their influence is great enough to risk the statement that successful therapeutic strategy must target CSCs in order to eradicate the disease. Because cancer stem cells are highly resistant to chemo- and radiotherapy, new tools to fight against cancer have to be developed. Expression of antigens such as ALDH, CD44, EpCAM, or CD133, which distinguish CSCs from normal cells, together with CSC immunogenicity and relatively low toxicity of immunotherapies, makes immune targeting of CSCs a promising approach for cancer treatment. This review will present immunotherapeutic approaches using dendritic cells, T cells, pluripotent stem cells, and monoclonal antibodies to target and eliminate CSCs.
Insights
Targeting cancer stem cells (CSCs) is crucial for eradicating cancer due to their resistance to conventional therapies. Immunotherapies offer a promising approach to eliminate these resilient tumour cells.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Cancer stem cells (CSCs) drive tumour initiation, progression, and resistance to chemo- and radiotherapy.
- Targeting CSCs is essential for effective cancer eradication.
- CSCs exhibit specific antigens (e.g., ALDH, CD44, EpCAM, CD133) and immunogenicity, making them amenable to immune-based therapies.
Purpose of the Study:
- To review promising immunotherapeutic strategies for targeting and eliminating cancer stem cells.
- To highlight the potential of immune-based approaches in overcoming CSC resistance.
Main Methods:
- Review of existing literature on CSCs and immunotherapies.
- Analysis of various immune-targeting modalities including dendritic cells, T cells, pluripotent stem cells, and monoclonal antibodies.
Main Results:
- CSCs are a critical target for durable cancer remission.
- Immunotherapies demonstrate potential for targeting CSCs with relatively low toxicity.
- Specific antigens on CSCs facilitate immune recognition and elimination.
Conclusions:
- Immune targeting of cancer stem cells represents a promising therapeutic avenue.
- Further development of immunotherapies is needed to effectively eliminate CSCs and eradicate cancer.
More Related Videos
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

